Zihipp is developing multiple analogues of oxyntomodulin, a hormone that controls body weight despite considerable variations in daily food intake and energy expenditure, resulting in the benefits of gastric bypass procedures without the drawbacks of surgery.  These analogues are potent and long-lasting suitable for subcutaneous administration (daily or weekly), pump-based administration (for example as a digiceutical), or as a convenient oral pill formulation.

[Oxyntomodulin analogue pipeline of products]